| Literature DB >> 18330604 |
L Hagelskjaer Kristensen1, J Prag.
Abstract
In a 3-year prospective study, all cases of disseminated Fusobacterium necrophorum infections found in Denmark from 1998 to 2001 were analysed, with the aim of describing the epidemiology and clinical features of the variants of Lemierre's syndrome and disseminated non-head-and-neck-associated F. necrophorum infections. Fifty-eight cases of Lemierre's syndrome were reported in previously healthy persons, with an incidence of 14.4 cases per million per year in youngsters aged 15-24 years old. There was no increase during the study period. Lemierre's syndrome originating from an oropharyngeal infection was seen in 37 youngsters. An otogenic variant of Lemierre's syndrome was seen in 5 children with dissemination to nearby regions, and other variants of Lemierre's syndrome, e.g. from the sinuses and teeth, were seen in 16 adults. Patients often had metastatic infections already on admission and needed prolonged hospitalisation. The overall mortality of Lemierre's syndrome was 9%. Forty-two elderly patients had disseminated F. necrophorum infections originating from foci in lower parts of the body. They frequently had predisposing diseases, e.g. abdominal or urogenital cancers, which contributed to the high mortality of 26%. This study shows that the incidence of Lemierre's syndrome is higher than that previously found and has a characteristic age distribution. Early suspicion of the diagnosis, several weeks of antibiotic therapy, often combined with surgical drainage, is mandatory to lower the mortality. In disseminated non-head-and-neck-associated F. necrophorum infections, underlying cancers must be considered.Entities:
Mesh:
Year: 2008 PMID: 18330604 PMCID: PMC7102232 DOI: 10.1007/s10096-008-0496-4
Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN: 0934-9723 Impact factor: 3.267
Variants of Lemierre’s syndrome in Denmark, 1998–2001; demography, microbiology, clinical chemistry, metastatic infections, antibiotic therapy and outcome
| Primary infectious foci | Ear | Throat | Other foci in the head* | Presumable foci in the head | Total number |
|---|---|---|---|---|---|
|
|
|
|
|
| |
| Demography | |||||
| Age in years, median (range) | 2 (0–16) | 20 (6–66) | 24 (7−84) | 55 (24−89) | 20 (0−89) |
| Male/female ratio in no. | 2/3 | 22/15 | 5/3 | 4/4 | 33/25 |
| Predisposing diseases in no. | 0 | 1** | 0 | 1*** | 2 |
| Microbiology with | |||||
| In blood, as the only pathogen/in mixed culture | 1/0 | 22/7 | 1/0 | 3/2 | 27/9 |
| In pus or swabs only, as the only pathogen/in mixed culture | 4/0 | 4/4 | 3/4 | 3/0 | 14/8 |
| Metastatic infections in no. | |||||
| Pleuropulmonary infection | 1 | 21 | 3 | 8 | 33 |
| Pneumonia complicated by pleural empyema | 0 | 8 | 2 | 3 | 13 |
| Pneumonia complicated by lung abscesses | 0 | 10 | 0 | 3 | 13 |
| Pneumonia complicated by mediastinitis | 0 | 1 | 1 | 0 | 2 |
| Parapharyngeal abscess | 0 | 0 | 4 | 0 | 4 |
| Meningeal empyema or meningitis | 2 | 4 | 1 | 0 | 7 |
| Mastoiditis | 5 | 1 | 0 | 0 | 6 |
| Subcutaneous abscesses | 0 | 5 | 1 | 1 | 7 |
| Positive blood culture as the only dissemination | 0 | 11 | 1 | 0 | 12 |
| Clinical chemistry findings on admission, median (range) | |||||
| White blood cell count, normal level 4–10 × 109/l | 12 (9–20) | 15 (2–44) | 12 (5–53) | 17 (14–19) | 15 (2–44) |
| Band neutrophilia, normal level <5% | 31 (13–43) | 24 (0–78) | – | – | 25 (0–78) |
| C-reactive protein, normal level <10 mg/l | 119 (63–192) | 223 (34–396) | 140 (33–424) | 238 (104–364) | 193 (33–424) |
| Thrombocyte count, normal level 150–450 × 109/l | 203 (129–249) | 136 (28–526) | 184 (142–335) | 405 (53–811) | 161 (28–811) |
| Bilirubinaemia, normal level 20–28 μmol/ml | – | 23 (5–157) | 10 (7–18) | – | 18 (5–157) |
| Course of the infection in days, median (range) | |||||
| Duration of relevant antibiotic therapy | 30 (18–90) | 27 (5–181) | 16 (2–61) | 10 (0–56) | 21 (0–181) |
| Duration of fever during antibiotic therapy | 14 (2–20) | 8 (1–55) | 9 (1–39) | 5 (3–20) | 9 (1–55) |
| Admission time | 17 (4–27) | 21 (1–151) | 13 (0–30) | 11 (0–30) | 17 (0–215) |
| Course of the infection in no. | |||||
| Admission to intensive care unit | 0 | 11 | 5 | 1 | 17 (30%) |
| Ventilator assistance | 0 | 7 | 3 | 0 | 10 (17%) |
| Surgical incision (e.g. drainage) | 5 | 16 | 8 | 2 | 31 (53%) |
| Recovery without sequelae, but often long convalescence | 5 | 33 | 5 | 5 | 48 (83%) |
| Permanent cerebral and/or pulmonary sequelae | 0 | 3 | 2 | 0 | 5 (9%) |
| Deaths in no. | 0 | 1 | 1 | 3 | 5 (9%) |
– No data available
*Four parapharyngeal abscesses, two dental infections, one meningitis and one sinusitis
**Intravenous drug abuse
*** Diabetes mellitus
Non-head-and-neck-associated disseminated Fusobacterium necrophorum infections in Denmark, 1998–2001; demography, predisposing diseases, microbiology, clinical chemistry, antibiotic therapy and outcome
| Primary infectious foci | Gastrointestinal tract | Urogenital tract | Unknown foci | Total |
|---|---|---|---|---|
|
|
|
|
| |
| Demography | ||||
| Age in years, median (range) | 61 (5–89) | 78 (25–96) | 76 (66–87) | 66 (5–96) |
| Male/female ratio in no. | 20/10 | 4/2 | 5/1 | 29/13 |
| Predisposing disease, cancer related to primary focus in no. | 11 | 3 | 0 | 14 |
| Predisposing diseases, others*, in no. | 7 | 1 | 5 | 13 |
| Microbiology with | ||||
| In blood, as the only pathogen/in mixed culture | 13/3 | 1/2 | 4/1 | 18/6 |
| In pus or swabs only, as the only pathogen/in mixed culture | 1/13 | 2/1 | 1/0 | 4/14 |
| Metastatic infections in no. | ||||
| Pneumonia | 1 | 0 | – | 1 |
| Intra-abdominal/urogenital abscesses | 19/0 | 0/3 | – | 19/3 |
| Subcutaneous abscesses | 1 | 0 | 1 | 2 |
| Positive blood culture as the only dissemination | 11 | 3 | – | 14 |
| Clinical chemistry findings on admission in median (range) | ||||
| White blood cell count, normal level 4–10 × 109/l | 18 (7–73) | 17 (8–29) | 10 (4–22) | 17 (4–73) |
| Band neutrophilia, normal level <5% | 8 (0–54) | – | 1 (0–5) | 5 (0–54) |
| C-reactive protein level, normal level <10 mg/l | 170 (7–379) | 247 (110–330) | 115 (10–322) | 170 (7–379) |
| Thrombocyte count, normal level 150–450 × 109/l | 252 (72–679) | 330 (199–500) | 162 (58–508) | 263 (58–679) |
| Bilirubinaemia, normal level 20–28 μmol/ml | 18 (7–324) | 9 (9–11) | 14 (9–20) | 12 (7–324) |
| Course of the infection in days, median (range) | ||||
| Duration of antibiotic therapy | 7 (0–41) | 10 (2–13) | 13 (0–37) | 10 (0–41) |
| Duration of fever during antibiotic therapy | 5 (0–52) | 3 (2–13) | 11 (0–44) | 5 (0–52) |
| Admission time | 16 (0–60) | 11 (3–35) | 10 (1–69) | 15 (0–69) |
| Deaths in no. | 8 | 2 | 1 | 11 (26%) |
– No data available
*Other predisposing diseases were immunosuppressive therapy, intravenous drug or alcohol abuse, diabetes and cancers not related to primary infectious focus